1. Home
  2. NPFD vs PRME Comparison

NPFD vs PRME Comparison

Compare NPFD & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Variable Rate Preferred & Income Fund

NPFD

Nuveen Variable Rate Preferred & Income Fund

HOLD

Current Price

$18.17

Market Cap

474.6M

Sector

Finance

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.48

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPFD
PRME
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.6M
666.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
NPFD
PRME
Price
$18.17
$3.48
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$7.56
AVG Volume (30 Days)
63.9K
2.4M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,632,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
55.28
52 Week Low
$16.79
$1.11
52 Week High
$20.12
$6.94

Technical Indicators

Market Signals
Indicator
NPFD
PRME
Relative Strength Index (RSI) 35.77 45.47
Support Level N/A $3.19
Resistance Level $19.62 $4.74
Average True Range (ATR) 0.36 0.24
MACD -0.12 -0.04
Stochastic Oscillator 32.22 47.89

Price Performance

Historical Comparison
NPFD
PRME

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: